Condition
Metastatic Endometrial Cancer clinical trials and research
As of November 12, 2026, Find a Trial lists 4 Metastatic Endometrial Cancer clinical trials that are recruiting, at sites in 3 countries (most in United States (3), South Korea (1), Australia (1)). By phase: Phase 1 (3), Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 3Countries
Newest Metastatic Endometrial Cancer clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| One year vs two years of maintenance immunotherapy for endometrial cancer | Phase 3 | Cary, North Carolina and 5 other locations | Recruiting | Oct 9, 2026 |
| ARR-002 in advanced ovarian or endometrial cancer | Phase 1 | Orlando, Florida and 5 other locations | Recruiting | Aug 10, 2026 |
| Evaluating NKT3964 for Adults with Advanced Solid Tumors | Phase 1 | Little Rock, Arkansas and 20 other locations | Recruiting | Sep 19, 2024 |
| Testing ERX-315 in patients with advanced solid tumors | Phase 1 | Ryde, New South Wales and 4 other locations | Recruiting | Aug 1, 2024 |
All recruiting trials (4)
-
One year vs two years of maintenance immunotherapy for endometrial cancer
This trial tests whether keeping pembrolizumab or dostarlimab for one year works as well as two years for people with advanced, recurrent, or metastatic endometrial cancer who completed initial chemo and anti-PD1 therapy.
-
ARR-002 in advanced ovarian or endometrial cancer
This phase 1 study tests ARR-002 to see if it is safe and tolerable in adults with advanced or metastatic ovarian or endometrial cancer who have limited treatment options.
-
Evaluating NKT3964 for Adults with Advanced Solid Tumors
This study is testing a new drug called NKT3964 to see if it can safely help adults with advanced solid tumors, like ovarian or triple-negative breast cancer, after other treatments have failed.
-
Testing ERX-315 in patients with advanced solid tumors
This study is testing a new treatment called ERX-315 to see if it is safe and effective for people with advanced solid tumors that haven't responded to other therapies.
Related topics
Quick answers
How many Metastatic Endometrial Cancer clinical trials are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in United States (3 trials), South Korea (1 trial), Australia (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 3, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.